Header Logo

Connection

BILAL OMER to Neoplasm Grading

Back to Details
This is a "connection" page, showing publications BILAL OMER has written about Neoplasm Grading.
BILAL OMER
Connection Strength
0.165
Neoplasm Grading
  1. Phase I Trial of GD2.CART Cells Augmented With Constitutive Interleukin-7 Receptor for Treatment of High-Grade Pediatric CNS Tumors. J Clin Oncol. 2024 Aug 10; 42(23):2769-2779.
    View in: PubMed
    Score: 0.165
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.